Pharma & Healthcare

Global Dermatology Drug Market Research Report 2026

This report delivers a comprehensive overview of the global Dermatology Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dermatology Drug. The Dermatology Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dermatology Drug market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dermatology Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Segment by Type
External Use
Oral
Injection
Segment by Application
Psoriasis
Skin Infections
Acne
Dermatitis
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Dermatology Drug companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Market by Application
1.3.1 Global Dermatology Drug Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatology Drug Market Perspective (2021–2032)
2.2 Global Dermatology Drug Growth Trends by Region
2.2.1 Global Dermatology Drug Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Dermatology Drug Historic Market Size by Region (2021–2026)
2.2.3 Dermatology Drug Forecasted Market Size by Region (2027–2032)
2.3 Dermatology Drug Market Dynamics
2.3.1 Dermatology Drug Industry Trends
2.3.2 Dermatology Drug Market Drivers
2.3.3 Dermatology Drug Market Challenges
2.3.4 Dermatology Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatology Drug Players by Revenue
3.1.1 Global Top Dermatology Drug Players by Revenue (2021–2026)
3.1.2 Global Dermatology Drug Revenue Market Share by Players (2021–2026)
3.2 Global Top Dermatology Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Dermatology Drug Revenue
3.4 Global Dermatology Drug Market Concentration Ratio
3.4.1 Global Dermatology Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology Drug Revenue in 2025
3.5 Global Key Players of Dermatology Drug Head Offices and Areas Served
3.6 Global Key Players of Dermatology Drug, Products and Applications
3.7 Global Key Players of Dermatology Drug, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Dermatology Drug Breakdown Data by Type
4.1 Global Dermatology Drug Historic Market Size by Type (2021–2026)
4.2 Global Dermatology Drug Forecasted Market Size by Type (2027–2032)
5 Dermatology Drug Breakdown Data by Application
5.1 Global Dermatology Drug Historic Market Size by Application (2021–2026)
5.2 Global Dermatology Drug Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Dermatology Drug Market Size (2021–2032)
6.2 North America Dermatology Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Dermatology Drug Market Size by Country (2021–2026)
6.4 North America Dermatology Drug Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatology Drug Market Size (2021–2032)
7.2 Europe Dermatology Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Dermatology Drug Market Size by Country (2021–2026)
7.4 Europe Dermatology Drug Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Dermatology Drug Market Size (2021–2032)
8.2 Asia-Pacific Dermatology Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Dermatology Drug Market Size by Region (2021–2026)
8.4 Asia-Pacific Dermatology Drug Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Dermatology Drug Market Size (2021–2032)
9.2 Latin America Dermatology Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Dermatology Drug Market Size by Country (2021–2026)
9.4 Latin America Dermatology Drug Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatology Drug Market Size (2021–2032)
10.2 Middle East & Africa Dermatology Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Dermatology Drug Market Size by Country (2021–2026)
10.4 Middle East & Africa Dermatology Drug Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Dermatology Drug Introduction
11.1.4 AbbVie Revenue in Dermatology Drug Business (2021–2026)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Dermatology Drug Introduction
11.2.4 Johnson & Johnson Revenue in Dermatology Drug Business (2021–2026)
11.2.5 Johnson & Johnson Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Dermatology Drug Introduction
11.3.4 Bayer Revenue in Dermatology Drug Business (2021–2026)
11.3.5 Bayer Recent Development
11.4 Galderma
11.4.1 Galderma Company Details
11.4.2 Galderma Business Overview
11.4.3 Galderma Dermatology Drug Introduction
11.4.4 Galderma Revenue in Dermatology Drug Business (2021–2026)
11.4.5 Galderma Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Dermatology Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Dermatology Drug Business (2021–2026)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Dermatology Drug Introduction
11.6.4 Novartis Revenue in Dermatology Drug Business (2021–2026)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Dermatology Drug Introduction
11.7.4 Pfizer Revenue in Dermatology Drug Business (2021–2026)
11.7.5 Pfizer Recent Development
11.8 Merz Pharma
11.8.1 Merz Pharma Company Details
11.8.2 Merz Pharma Business Overview
11.8.3 Merz Pharma Dermatology Drug Introduction
11.8.4 Merz Pharma Revenue in Dermatology Drug Business (2021–2026)
11.8.5 Merz Pharma Recent Development
11.9 Valeant
11.9.1 Valeant Company Details
11.9.2 Valeant Business Overview
11.9.3 Valeant Dermatology Drug Introduction
11.9.4 Valeant Revenue in Dermatology Drug Business (2021–2026)
11.9.5 Valeant Recent Development
11.10 LEO Pharma
11.10.1 LEO Pharma Company Details
11.10.2 LEO Pharma Business Overview
11.10.3 LEO Pharma Dermatology Drug Introduction
11.10.4 LEO Pharma Revenue in Dermatology Drug Business (2021–2026)
11.10.5 LEO Pharma Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Dermatology Drug Introduction
11.11.4 GlaxoSmithKline Revenue in Dermatology Drug Business (2021–2026)
11.11.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Dermatology Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of External Use
Table 3. Key Players of Oral
Table 4. Key Players of Injection
Table 5. Global Dermatology Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Dermatology Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Dermatology Drug Market Size by Region (US$ Million), 2021–2026
Table 8. Global Dermatology Drug Market Share by Region (2021–2026)
Table 9. Global Dermatology Drug Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Dermatology Drug Market Share by Region (2027–2032)
Table 11. Dermatology Drug Market Trends
Table 12. Dermatology Drug Market Drivers
Table 13. Dermatology Drug Market Challenges
Table 14. Dermatology Drug Market Restraints
Table 15. Global Dermatology Drug Revenue by Players (US$ Million), 2021–2026
Table 16. Global Dermatology Drug Market Share by Players (2021–2026)
Table 17. Global Top Dermatology Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Dermatology Drug Revenue, 2025
Table 18. Ranking of Global Top Dermatology Drug Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Dermatology Drug Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Dermatology Drug, Headquarters and Area Served
Table 21. Global Key Players of Dermatology Drug, Products and Applications
Table 22. Global Key Players of Dermatology Drug, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Dermatology Drug Market Size by Type (US$ Million), 2021–2026
Table 25. Global Dermatology Drug Revenue Market Share by Type (2021–2026)
Table 26. Global Dermatology Drug Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Dermatology Drug Revenue Market Share by Type (2027–2032)
Table 28. Global Dermatology Drug Market Size by Application (US$ Million), 2021–2026
Table 29. Global Dermatology Drug Revenue Market Share by Application (2021–2026)
Table 30. Global Dermatology Drug Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Dermatology Drug Revenue Market Share by Application (2027–2032)
Table 32. North America Dermatology Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Dermatology Drug Market Size by Country (US$ Million), 2021–2026
Table 34. North America Dermatology Drug Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Dermatology Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Dermatology Drug Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Dermatology Drug Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Dermatology Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Dermatology Drug Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Dermatology Drug Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Dermatology Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Dermatology Drug Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Dermatology Drug Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Dermatology Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Dermatology Drug Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Dermatology Drug Market Size by Country (US$ Million), 2027–2032
Table 47. AbbVie Company Details
Table 48. AbbVie Business Overview
Table 49. AbbVie Dermatology Drug Product
Table 50. AbbVie Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 51. AbbVie Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Dermatology Drug Product
Table 55. Johnson & Johnson Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 56. Johnson & Johnson Recent Development
Table 57. Bayer Company Details
Table 58. Bayer Business Overview
Table 59. Bayer Dermatology Drug Product
Table 60. Bayer Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 61. Bayer Recent Development
Table 62. Galderma Company Details
Table 63. Galderma Business Overview
Table 64. Galderma Dermatology Drug Product
Table 65. Galderma Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 66. Galderma Recent Development
Table 67. Bristol-Myers Squibb Company Details
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Dermatology Drug Product
Table 70. Bristol-Myers Squibb Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Dermatology Drug Product
Table 75. Novartis Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 76. Novartis Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Dermatology Drug Product
Table 80. Pfizer Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 81. Pfizer Recent Development
Table 82. Merz Pharma Company Details
Table 83. Merz Pharma Business Overview
Table 84. Merz Pharma Dermatology Drug Product
Table 85. Merz Pharma Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 86. Merz Pharma Recent Development
Table 87. Valeant Company Details
Table 88. Valeant Business Overview
Table 89. Valeant Dermatology Drug Product
Table 90. Valeant Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 91. Valeant Recent Development
Table 92. LEO Pharma Company Details
Table 93. LEO Pharma Business Overview
Table 94. LEO Pharma Dermatology Drug Product
Table 95. LEO Pharma Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 96. LEO Pharma Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Dermatology Drug Product
Table 100. GlaxoSmithKline Revenue in Dermatology Drug Business (US$ Million), 2021–2026
Table 101. GlaxoSmithKline Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report


List of Figures
Figure 1. Dermatology Drug Picture
Figure 2. Global Dermatology Drug Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Dermatology Drug Market Share by Type: 2025 vs 2032
Figure 4. External Use Features
Figure 5. Oral Features
Figure 6. Injection Features
Figure 7. Global Dermatology Drug Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Dermatology Drug Market Share by Application: 2025 vs 2032
Figure 9. Psoriasis Case Studies
Figure 10. Skin Infections Case Studies
Figure 11. Acne Case Studies
Figure 12. Dermatitis Case Studies
Figure 13. Others Case Studies
Figure 14. Dermatology Drug Report Years Considered
Figure 15. Global Dermatology Drug Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Dermatology Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Dermatology Drug Market Share by Region: 2025 vs 2032
Figure 18. Global Dermatology Drug Market Share by Players in 2025
Figure 19. Global Dermatology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Dermatology Drug Revenue in 2025
Figure 21. North America Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Dermatology Drug Market Share by Country (2021–2032)
Figure 23. United States Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Dermatology Drug Market Share by Country (2021–2032)
Figure 27. Germany Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Dermatology Drug Market Share by Region (2021–2032)
Figure 35. China Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Dermatology Drug Market Share by Country (2021–2032)
Figure 43. Mexico Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Dermatology Drug Market Share by Country (2021–2032)
Figure 47. Israel Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Dermatology Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. AbbVie Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 51. Johnson & Johnson Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 52. Bayer Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 53. Galderma Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 55. Novartis Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 56. Pfizer Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 57. Merz Pharma Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 58. Valeant Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 59. LEO Pharma Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Dermatology Drug Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies